A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and the Effect on Survival in Bladder Cancer Patients

European urology oncology - Tập 3 - Trang 239-249 - 2020
Beth Russell1, Fredrik Liedberg2,3, Muhammad Shamim Khan4, Rajesh Nair4, Ramesh Thurairaja4, Sachin Malde4, Pardeep Kumar5, Richard T. Bryan6, Mieke Van Hemelrijck1
1Department of Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK
2Department of Urology, Skåne University Hospital, Malmö, Sweden
3Institution of Translational Medicine, Lund University, Malmö, Sweden
4Department of Urology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
5The Royal Marsden NHS Foundation Trust, London, UK
6Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Tài liệu tham khảo

World Cancer Research Fund European Network of Cancer Registries American Cancer Society Wu, 2005, Urothelial tumorigenesis: a tale of divergent pathways, Nat Rev Cancer, 5, 713, 10.1038/nrc1697 Fahmy, 2006, Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature, Eur Urol, 50, 1176, 10.1016/j.eururo.2006.05.046 Babjuk, 2015, Guidelines on non-muscle-invasive bladder cancer (Ta, T1 and CIS), European Association of Urology Witjes Bessa, 2019, Consensus in bladder cancer research priorities between patients and healthcare professionals using a four-stage modified Delphi method, Eur Urol, 76, 258, 10.1016/j.eururo.2019.01.031 Williams, 2019, Systematic review of factors associated with the utilization of radical cystectomy for bladder cancer, Eur Urol Oncol, 2, 119, 10.1016/j.euo.2018.07.006 Tomaszewski, 2014, Care transitions between hospitals are associated with treatment delay for patients with muscle invasive bladder cancer, J Urol, 192, 1349, 10.1016/j.juro.2014.05.027 Vandenbroucke, 2007, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration, Epidemiology, 18, 805, 10.1097/EDE.0b013e3181577511 Sterne, 2016, ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions, BMJ, 355, i4919, 10.1136/bmj.i4919 Munro, 2010, A 10-year retrospective review of a nonrandomized cohort of 458 patients undergoing radical radiotherapy or cystectomy in Yorkshire, UK, Int J Radiat Oncol, 77, 119, 10.1016/j.ijrobp.2009.04.050 Kahokehr, 2016, Surgical waiting time for radical cystectomy: a New Zealand experience, ANZ J Surg, 86, 1042, 10.1111/ans.13282 Gulliford, 1991, Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment, BMJ, 303, 437, 10.1136/bmj.303.6800.437 Williams, 2017, Survival differences among patients with bladder cancer according to sex: Critical evaluation of radical cystectomy use and delay to treatment, Urol Oncol Semin Orig Investig, 35, 602 Santos, 2015, Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer, Curr Oncol, 22, e20, 10.3747/co.22.2052 Mahmud, 2006, Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study, J Urol, 175, 78, 10.1016/S0022-5347(05)00070-4 Kulkarni, 2009, Longer wait times increase overall mortality in patients with bladder cancer, J Urol, 182, 1318, 10.1016/j.juro.2009.06.041 Audenet, 2019, A delay ≥8 weeks to neoadjuvant chemotherapy before radical cystectomy increases the risk of upstaging, Urol Oncol Semin Orig Investig, 37, 116, 10.1016/j.urolonc.2018.11.011 Boeri, 2019, Delaying radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer is associated with adverse survival outcomes, Eur Urol Oncol, 2, 390, 10.1016/j.euo.2018.09.004 Lee, 2006, Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival, J Urol, 175, 1262, 10.1016/S0022-5347(05)00644-0 Gore, 2009, Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a SEER Medicare analysis, Cancer, 115, 988, 10.1002/cncr.24052 Liedberg, 2005, Treatment delay and prognosis in invasive bladder cancer, J Urol, 174, 1777, 10.1097/01.ju.0000177521.72678.61 May, 2004, Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder, Scand J Urol Nephrol, 38, 231, 10.1080/00365590410029141 Fahmy, 2008, An analysis of preoperative delays prior to radical cystectomy for bladder cancer in Quebec, CUAJ, 2, 102, 10.5489/cuaj.482 Jäger, 2011, Early vs delayed radical cystectomy for “high-risk” carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival, BJU Int, 108 Nielsen, 2007, A delay in radical cystectomy of &3 months is not associated with a worse clinical outcome, BJU Int, 100, 1015, 10.1111/j.1464-410X.2007.07132.x Chu, 2019, Delays in radical cystectomy for muscle‐invasive bladder cancer, Cancer, 125, 2011, 10.1002/cncr.32048 Bruins, 2016, The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: a Netherlands Cancer Registry analysis, Urol Oncol, 34, 166, 10.1016/j.urolonc.2015.11.006 Alva, 2012, Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: a multidisciplinary approach, Cancer, 118, 44, 10.1002/cncr.26240 Afshar, 2018, Centralisation of radical cystectomies for bladder cancer in England, a decade on from the ‘improving outcomes guidance’: the case for super centralisation, BJU Int, 121, 217, 10.1111/bju.13929 Xia, 2018, Associations between travel distance, hospital volume, and outcomes following radical cystectomy in patients with muscle-invasive bladder cancer, Urology, 114, 87, 10.1016/j.urology.2017.12.014 Advanced Bladder Cancer Overview Collaboration, 2005, Neoadjuvant chemotherapy for invasive bladder cancer, Cochrane Database Syst Rev, 2 Sherif, 2004, Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies, Eur Urol, 45, 297, 10.1016/j.eururo.2003.09.019 Huo, 2019, Discerning patterns and quality of neoadjuvant chemotherapy use among patients with muscle-invasive bladder cancer, Eur Urol Oncol, 2, 497, 10.1016/j.euo.2018.07.009 Bryan, 2015, A comparative analysis of the influence of gender, pathway delays, and risk factor exposures on the long-term outcomes of bladder cancer, Eur Urol Focus, 1, 82, 10.1016/j.euf.2015.01.001 Nilbert, 2018, Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria, Scand J Urol, 52, 237, 10.1080/21681805.2018.1498124 Hansen, 2011, Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients, Vol. 11 Bourgade, 2014, Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival, World J Urol, 32, 475, 10.1007/s00345-013-1045-z Wallace, 2002, Delay and survival in bladder cancer, BJU Int, 89, 868, 10.1046/j.1464-410X.2002.02776.x